OptimizeRx PE Ratio 2009-2021 | OPRX

Current and historical p/e ratio for OptimizeRx (OPRX) from 2009 to 2021. The price to earnings ratio is calculated by taking the latest closing price and dividing it by the most recent earnings per share (EPS) number. The PE ratio is a simple way to assess whether a stock is over or under valued and is the most widely used valuation measure. OptimizeRx PE ratio as of January 21, 2022 is 365.00.

Please refer to the Stock Price Adjustment Guide for more information on our historical prices.

OptimizeRx PE Ratio Historical Data
Date Stock Price TTM Net EPS PE Ratio
2022-01-21 41.97 299.79
2021-09-30 85.55 $0.14 611.07
2021-06-30 61.90 $0.12 515.83
2021-03-31 48.75 $0.03 1625.00
2020-12-31 31.16 $-0.16 0.00
2020-09-30 20.85 $-0.38 0.00
2020-06-30 13.03 $-0.47 0.00
2020-03-31 9.06 $-0.37 0.00
2019-12-31 10.27 $-0.22 0.00
2019-09-30 14.48 $-0.09 0.00
2019-06-30 16.20 $0.04 405.00
2019-03-31 12.72 $0.03 424.00
Sector Industry Market Cap Revenue
Computer and Technology Computer Software $0.778B $0.043B
OptimizeRx Corporation provides consumer and physician platforms to help patients better afford and comply with their medicines and healthcare products. It offers pharmaceutical and healthcare companies effective ways to expand patient awareness, access and adherence to their brands. The Company offers marketing and advertising solutions by connecting patients, physicians, and pharmaceutical manufacturers through its consumer Websites. OptimizeRx Corporation is based in Rochester, Michigan.
Stock Name Country Market Cap PE Ratio
Oracle (ORCL) United States $220.899B 18.42
Salesforce, Inc (CRM) United States $219.596B 76.09
SAP SE (SAP) Germany $168.317B 21.89
VMware (VMW) United States $52.327B 23.76
BlackBerry (BB) Canada $5.109B 0.00
PROS Holdings (PRO) United States $1.190B 0.00